Viewing Study NCT04558866


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-01-19 @ 10:42 AM
Study NCT ID: NCT04558866
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-02
First Post: 2020-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
Sponsor: Latin American Cooperative Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module